MEDIFAST Financial Statements From 2010 to 2024

MED Stock  USD 18.14  0.14  0.77%   
MEDIFAST INC financial statements provide useful quarterly and yearly information to potential MEDIFAST INC investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on MEDIFAST INC financial statements helps investors assess MEDIFAST INC's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting MEDIFAST INC's valuation are summarized below:
Gross Profit
1.1 B
Profit Margin
0.0109
Market Capitalization
198.4 M
Enterprise Value Revenue
0.0683
Revenue
674.5 M
There are over one hundred nineteen available fundamental ratios for MEDIFAST INC, which can be analyzed over time and compared to other ratios. Investors should ensure to check all of MEDIFAST INC's last-minute performance against the performance from 2010 to 2024 to make sure the company is sustainable in the future. The current year's Market Cap is expected to grow to about 465.9 M. The current year's Enterprise Value is expected to grow to about 417.1 M

MEDIFAST INC Total Revenue

1.13 Billion

Check MEDIFAST INC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MEDIFAST INC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 13.8 M, Interest Expense of 2.6 M or Selling General Administrative of 678.4 M, as well as many indicators such as Price To Sales Ratio of 0.65, Dividend Yield of 0.1 or PTB Ratio of 4.14. MEDIFAST financial statements analysis is a perfect complement when working with MEDIFAST INC Valuation or Volatility modules.
  
Check out the analysis of MEDIFAST INC Correlation against competitors.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.

MEDIFAST INC Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets325.4 M309.9 M191.4 M
Slightly volatile
Short and Long Term Debt Total23.1 M22 M11.4 M
Slightly volatile
Other Current Liabilities50.9 M48.5 M30.4 M
Slightly volatile
Total Current Liabilities96.9 M92.3 M62.9 M
Slightly volatile
Total Stockholder Equity211.6 M201.5 M118.9 M
Slightly volatile
Property Plant And Equipment Net70.5 M67.1 M41 M
Slightly volatile
Cash99.2 M94.4 M66.2 M
Slightly volatile
Non Current Assets Total90.2 M85.9 M46.7 M
Slightly volatile
Cash And Short Term Investments157.5 M150 M88.7 M
Slightly volatile
Common Stock Total Equity12.3 K12.7 K12.1 K
Very volatile
Common Stock Shares Outstanding12.2 M10.9 M11.8 M
Very volatile
Liabilities And Stockholders Equity325.4 M309.9 M191.4 M
Slightly volatile
Non Current Liabilities Total16.9 M16.1 M9.7 M
Slightly volatile
Inventory27.8 M54.6 M43.4 M
Slightly volatile
Other Current Assets20.4 M19.4 M10 M
Slightly volatile
Total Liabilities113.8 M108.4 M72.5 M
Slightly volatile
Property Plant And Equipment Gross120.1 M114.4 M52.3 M
Slightly volatile
Total Current Assets235.2 M224 M144.7 M
Slightly volatile
Common Stock12.2 K12.7 K12.1 K
Very volatile
Accounts Payable21.4 M39.2 M31.8 M
Slightly volatile
Other Assets21.5 M20.5 M6.5 M
Slightly volatile
Property Plant Equipment69.1 M65.8 M36.2 M
Slightly volatile
Net Tangible Assets125 M178.3 M115.9 M
Slightly volatile
Retained Earnings Total Equity126.9 M160.8 M115.5 M
Slightly volatile
Other Liabilities177.8 K187.2 K1.3 M
Slightly volatile
Short and Long Term Debt277.2 K197.1 K306.4 K
Slightly volatile
Non Current Liabilities Other246.2 K259.2 K1.1 M
Slightly volatile
Cash And Equivalents100.8 M100.8 M77.2 M
Slightly volatile
Net Invested Capital163.2 M201.5 M130.8 M
Slightly volatile
Net Working Capital113.4 M131.7 M96.8 M
Slightly volatile
Capital Stock9.3 K9.9 K11.6 K
Slightly volatile
Deferred Long Term Asset Charges2.4 M2.7 M2.9 M
Slightly volatile

MEDIFAST INC Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization13.8 M13.1 M8.6 M
Slightly volatile
Selling General Administrative678.4 M646 M394 M
Slightly volatile
Total Revenue1.1 B1.1 B642.3 M
Slightly volatile
Gross Profit814.6 M775.9 M472.3 M
Slightly volatile
Other Operating Expenses992.9 M945.7 M564.7 M
Slightly volatile
Operating Income132.7 M126.4 M77.6 M
Slightly volatile
EBIT132.7 M126.4 M77.3 M
Slightly volatile
EBITDA146.5 M139.5 M85.9 M
Slightly volatile
Cost Of Revenue311 M296.2 M170 M
Slightly volatile
Total Operating Expenses681.9 M649.4 M394.7 M
Slightly volatile
Income Before Tax135.2 M128.8 M78.5 M
Slightly volatile
Net Income104.4 M99.4 M59 M
Slightly volatile
Net Income Applicable To Common Shares173.4 M165.1 M68 M
Slightly volatile
Net Income From Continuing Ops73.5 M119.9 M64.1 M
Slightly volatile
Selling And Marketing Expenses3.2 M3.4 M11.5 M
Slightly volatile
Tax Provision26.5 M31.5 M19.6 M
Slightly volatile
Interest Income2.6 M2.5 M912.7 K
Slightly volatile
Reconciled DepreciationM12.7 M5.9 M
Slightly volatile

MEDIFAST INC Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow92.1 M87.7 M60.5 M
Slightly volatile
Depreciation13.8 M13.1 M7.8 M
Slightly volatile
Capital Expenditures7.2 M6.5 M9.3 M
Pretty Stable
Net Income104.4 M99.4 M59.5 M
Slightly volatile
End Period Cash Flow99.2 M94.4 M66.2 M
Slightly volatile
Stock Based Compensation4.6 M8.2 M4.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.650.68241.4493
Pretty Stable
Dividend Yield0.10.09980.0348
Slightly volatile
PTB Ratio4.143.63126.8916
Slightly volatile
Days Sales Outstanding0.250.263.284
Slightly volatile
Book Value Per Share19.4418.511710.1186
Slightly volatile
Stock Based Compensation To Revenue0.00730.00760.0089
Slightly volatile
Capex To Depreciation0.470.49461.2255
Pretty Stable
PB Ratio4.143.63126.8916
Slightly volatile
EV To Sales0.580.61491.3572
Pretty Stable
ROIC0.490.47050.4011
Slightly volatile
Inventory Turnover5.75.42594.0929
Pretty Stable
Net Income Per Share9.599.1345.0958
Slightly volatile
Days Of Inventory On Hand63.9167.270295.9989
Pretty Stable
Payables Turnover4.917.55766.2599
Slightly volatile
Sales General And Administrative To Revenue0.480.60260.5911
Slightly volatile
Research And Ddevelopement To Revenue0.00490.00430.0045
Slightly volatile
Capex To Revenue0.00570.0060.0174
Slightly volatile
Cash Per Share14.4713.78557.5284
Slightly volatile
Interest Coverage249237285
Slightly volatile
Days Payables Outstanding71.3248.295962.6259
Slightly volatile
ROE0.840.49340.4359
Slightly volatile
PE Ratio6.997.359319.7152
Slightly volatile
Return On Tangible Assets0.340.32080.2507
Slightly volatile
Earnings Yield0.140.13590.0658
Slightly volatile
Intangibles To Total Assets0.00360.00380.007
Slightly volatile
Current Ratio2.312.42722.6649
Slightly volatile
Tangible Book Value Per Share19.4418.511710.1026
Slightly volatile
Receivables Turnover1.5 K1.4 K704
Slightly volatile
Graham Number64.7661.680232.8877
Slightly volatile
Shareholders Equity Per Share19.4418.511710.1186
Slightly volatile
Debt To Equity0.0210.02920.0982
Slightly volatile
Capex Per Share0.440.59560.7538
Slightly volatile
Revenue Per Share10398.498255.1971
Slightly volatile
Interest Debt Per Share0.350.54070.4533
Slightly volatile
Debt To Assets0.0180.0190.0529
Slightly volatile
Enterprise Value Over EBITDA6.964.725111.0317
Pretty Stable
Price Earnings Ratio6.997.359319.7152
Slightly volatile
Operating Cycle63.9167.270299.2185
Pretty Stable
Price Book Value Ratio4.143.63126.8916
Slightly volatile
Days Of Payables Outstanding71.3248.295962.6259
Slightly volatile
Pretax Profit Margin0.130.12010.1096
Slightly volatile
Ebt Per Ebit0.741.01890.9664
Pretty Stable
Operating Profit Margin0.120.11790.1082
Slightly volatile
Company Equity Multiplier1.061.53811.5612
Very volatile
Long Term Debt To Capitalization0.130.11560.0698
Slightly volatile
Total Debt To Capitalization0.0270.02840.0823
Pretty Stable
Return On Capital Employed0.610.58090.5097
Slightly volatile
Debt Equity Ratio0.0210.02920.0982
Slightly volatile
Ebit Per Revenue0.120.11790.1082
Slightly volatile
Quick Ratio1.541.83571.9507
Slightly volatile
Net Income Per E B T0.810.77190.7584
Very volatile
Cash Ratio0.671.02321.1387
Very volatile
Cash Conversion Cycle18.0318.974347.5575
Pretty Stable
Days Of Inventory Outstanding63.9167.270295.9989
Pretty Stable
Days Of Sales Outstanding0.250.263.284
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.920.95610.9264
Pretty Stable
Price To Book Ratio4.143.63126.8916
Slightly volatile
Fixed Asset Turnover16.7715.974114.6069
Slightly volatile
Enterprise Value Multiple6.964.725111.0317
Pretty Stable
Debt Ratio0.0180.0190.0529
Slightly volatile
Price Sales Ratio0.650.68241.4493
Pretty Stable
Return On Assets0.340.32080.2504
Slightly volatile
Asset Turnover1.83.45932.8643
Slightly volatile
Net Profit Margin0.09740.09270.0792
Slightly volatile
Gross Profit Margin0.540.72370.7097
Very volatile
Price Fair Value4.143.63126.8916
Slightly volatile
Return On Equity0.840.49340.4359
Slightly volatile

MEDIFAST INC Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap465.9 M443.7 M404.9 M
Slightly volatile
Enterprise Value417.1 M397.2 M364.9 M
Slightly volatile

MEDIFAST Fundamental Market Drivers

Cash And Short Term Investments150 M

MEDIFAST Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About MEDIFAST INC Financial Statements

MEDIFAST INC stakeholders use historical fundamental indicators, such as MEDIFAST INC's revenue or net income, to determine how well the company is positioned to perform in the future. Although MEDIFAST INC investors may analyze each financial statement separately, they are all interrelated. For example, changes in MEDIFAST INC's assets and liabilities are reflected in the revenues and expenses on MEDIFAST INC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in MEDIFAST INC. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue574 K545.3 K
Total Revenue1.1 B1.1 B
Cost Of Revenue296.2 M311 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.60  0.48 
Capex To Revenue 0.01  0.01 
Revenue Per Share 98.50  103.42 
Ebit Per Revenue 0.12  0.12 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether MEDIFAST INC is a strong investment it is important to analyze MEDIFAST INC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MEDIFAST INC's future performance. For an informed investment choice regarding MEDIFAST Stock, refer to the following important reports:
Check out the analysis of MEDIFAST INC Correlation against competitors.
For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.95)
Earnings Share
0.67
Revenue Per Share
61.769
Quarterly Revenue Growth
(0.41)
Return On Assets
0.0477
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.